Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI

NCT04951856 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

2166

Enrollment

OTHER

Sponsor class

Conditions

STEMI - ST Elevation Myocardial Infarction
NSTEMI - Non-ST Segment Elevation MI

Interventions

DRUG: Evolocumab 140 MG/ML
DRUG: Standard of care (SOC)

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]